CIK 0001799191 · Accelerated filer<br>Smaller reporting company
Starling Oncology, Inc.
Sign in to watch- Tickers
- STLN DFPH
- Exchange
- Nasdaq, OTC
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 843562323
- Phone
- 562-735-3226
- Business address
- 18000 STUDEBAKER RD, SUITE 800, CERRITOS, CA, 90703
- Former names
- Oncology Institute, Inc., DFP HEALTHCARE ACQUISITIONS CORP.
Securities
- STLN Common Stock Nasdaq
- STLNW Warrant Nasdaq
- DFPH Common stock OTC
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Grant or award Chief Clinical Officer acquired 57,380 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 2,000,000 shares at $2.71 ($5,425,800)
- 4 Returned to the company Chief Executive Officer returned 20,388 shares (to the company)
- 4 Returned to the company Chief Medical Officer returned 1,801 shares (to the company)
- 4 Returned to the company Chief Financial Officer returned 1,601 shares (to the company)
- 4 Returned to the company Chief Operating Officer returned 5,636 shares (to the company)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Regulation FD disclosure
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
Page 7 of 28 · 548 filings